Clinical Trials Browser

Phase 2 × Unknown × ceritinib × Clear all

NCT01964157 2019-01-11

An Open-label, Multicenter, Phase II Study of LDK378 in Patients With Non-small Cell Lung Cancer Harboring ROS1 Rearrangement

Phase 2 Unknown

Carcinoma, Non-Small-Cell Lung

NCT03399487 2019-01-11

A Study of LDK378 in Patients With Non-small Cell Lung Cancer Harboring ROS1 Rearrangement

Phase 2 Unknown

Non-small Cell Lung Cancer Harboring ROS1 Rearrangement